These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37332880)

  • 1. The VASCERN-VASCA Working Group Diagnostic and Management Pathways for Venous Malformations.
    Dompmartin A; Baselga E; Boon LM; Diociaiuti A; Dvorakova V; El Hachem M; Gasparella P; Haxhija E; Ghaffarpour N; Kyrklund K; Irvine AD; Kapp FG; Rößler J; Salminen P; van den Bosch C; van der Vleuten C; Schultze Kool L; Vikkula M
    J Vasc Anom (Phila); 2023 Jun; 4(2):e064. PubMed ID: 37332880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of gene-disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA.
    Revencu N; Eijkelenboom A; Bracquemart C; Alhopuro P; Armstrong J; Baselga E; Cesario C; Dentici ML; Eyries M; Frisk S; Karstensen HG; Gene-Olaciregui N; Kivirikko S; Lavarino C; Mero IL; Michiels R; Pisaneschi E; Schönewolf-Greulich B; Wieland I; Zenker M; Vikkula M
    Orphanet J Rare Dis; 2024 May; 19(1):213. PubMed ID: 38778413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformations.
    Ghaffarpour N; Baselga E; Boon LM; Diociaiuti A; Dompmartin A; Dvorakova V; El Hachem M; Gasparella P; Haxhija E; Kyrklund K; Irvine AD; Kapp FG; Rößler J; Salminen P; van den Bosch C; van der Vleuten C; Kool LS; Vikkula M
    Eur J Med Genet; 2022 Dec; 65(12):104637. PubMed ID: 36223836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomas.
    Diociaiuti A; Baselga E; Boon LM; Dompmartin A; Dvorakova V; El Hachem M; Gasparella P; Haxhija E; Ghaffarpour N; Kyrklund K; Irvine AD; Kapp FG; Rößler J; Salminen P; van den Bosch C; van der Vleuten C; Kool LS; Vikkula M
    Eur J Med Genet; 2022 Jun; 65(6):104517. PubMed ID: 35487416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VASCERN European Reference Network: An overview.
    Jondeau G; Hallac J; Hurard M; Daoud K; Barr N; Domnez I;
    Eur J Med Genet; 2022 Mar; 65(3):104420. PubMed ID: 35032690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eHealth for patients with rare diseases: the eHealth Working Group of the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN).
    Paglialonga A; Gaetano R; Robert L; Hurard M; Botella LM; Barr N; Jondeau G; Pini A
    Orphanet J Rare Dis; 2021 Apr; 16(1):164. PubMed ID: 33832526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The VASCERN PPL working group patient pathway for primary and paediatric lymphoedema.
    Devoogdt N; Thomis S; Belva F; Dickinson-Blok J; Fourgeaud C; Giacalone G; Karlsmark T; Kavola H; Keeley V; Marques ML; Mansour S; Nissen CV; Nørregaard S; Oberlin M; Ručigaj TP; Somalo-Barranco G; Suominen S; Van Duinen K; Vignes S; Damstra R
    Eur J Med Genet; 2024 Feb; 67():104905. PubMed ID: 38143023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013.
    Lee BB; Baumgartner I; Berlien P; Bianchini G; Burrows P; Gloviczki P; Huang Y; Laredo J; Loose DA; Markovic J; Mattassi R; Parsi K; Rabe E; Rosenblatt M; Shortell C; Stillo F; Vaghi M; Villavicencio L; Zamboni P;
    Int Angiol; 2015 Apr; 34(2):97-149. PubMed ID: 24566499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline. Diagnosis and treatment of venous malformations. consensus document of the international union of phlebology (iup): updated-2013.
    Lee BB; Baumgartner I; Berlien P; Bianchini G; Burrows P; Gloviczki P; Huang Y; Laredo J; Loose DA; Markovic J; Mattassi R; Parsi K; Rabe E; Rosenblatt M; Shortell C; Stillo F; Vaghi M; Villavicencio L; Zamboni P
    Int Angiol; 2014 Jun; ():. PubMed ID: 24961611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTAD patient pathway: Strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD). A statement from the HTAD working group of VASCERN.
    Caruana M; Baars MJ; Bashiardes E; Benke K; Björck E; Codreanu A; de Moya Rubio E; Dumfarth J; Evangelista A; Groenink M; Kallenbach K; Kempers M; Keravnou A; Loeys B; Muiño-Mosquera L; Nagy E; Milleron O; Nistri S; Pepe G; Roos-Hesselink J; Szabolcs Z; Teixidó-Tura G; Timmermans J; Van de Laar I; van Kimmenade R; Verstraeten A; Von Kodolitsch Y; De Backer J; Jondeau G
    Eur J Med Genet; 2023 Jan; 66(1):104673. PubMed ID: 36460281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary diagnosis and management of venous and arterio-venous shunting malformation by whole body blood pool scintigraphy.
    Lee BB; Mattassi R; Kim BT; Kim YW; Ahn JM; Choi JY
    Int Angiol; 2004 Dec; 23(4):355-67. PubMed ID: 15767981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care.
    Shovlin CL; Buscarini E; Sabbà C; Mager HJ; Kjeldsen AD; Pagella F; Sure U; Ugolini S; Torring PM; Suppressa P; Rennie C; Post MC; Patel MC; Nielsen TH; Manfredi G; Lenato GM; Lefroy D; Kariholu U; Jones B; Fialla AD; Eker OF; Dupuis O; Droege F; Coote N; Boccardi E; Alsafi A; Alicante S; Dupuis-Girod S
    Eur J Med Genet; 2022 Jan; 65(1):104370. PubMed ID: 34737116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities.
    Boon LM; Mulliken JB; Enjolras O; Vikkula M
    Arch Dermatol; 2004 Aug; 140(8):971-6. PubMed ID: 15313813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous venous malformations as a clue for possible gastrointestinal tract involvement: Diagnosis and treatment of six cases.
    Diociaiuti A; Rotunno R; Caldaro T; Rossi S; Carnevale C; Torroni F; Paolantonio G; Capriati T; El Hachem M
    Dermatol Ther; 2021 May; 34(3):e14932. PubMed ID: 33751718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics, clinical presentation, and treatment outcomes of venous malformation in the extremities.
    Kim H; Joh J; Labropoulos N
    J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):152-158. PubMed ID: 34091104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants.
    van de Laar IMBH; Arbustini E; Loeys B; Björck E; Murphy L; Groenink M; Kempers M; Timmermans J; Roos-Hesselink J; Benke K; Pepe G; Mulder B; Szabolcs Z; Teixidó-Turà G; Robert L; Emmanuel Y; Evangelista A; Pini A; von Kodolitsch Y; Jondeau G; De Backer J
    Orphanet J Rare Dis; 2019 Nov; 14(1):264. PubMed ID: 31752940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous Malformations in Childhood: Clinical, Histopathological and Genetics Update.
    Colmenero I; Knöpfel N
    Dermatopathology (Basel); 2021 Oct; 8(4):477-493. PubMed ID: 34698142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
    Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
    Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance and monitoring in vascular Ehlers-Danlos syndrome in European Reference Network For Rare Vascular Diseases (VASCERN).
    van de Laar IMBH; Baas AF; De Backer J; Blankenstein JD; Dulfer E; Helderman-van den Enden ATJM; Houweling AC; Kempers MJ; Loeys B; Malfait F; Robert L; Tanteles G; Frank M
    Eur J Med Genet; 2022 Sep; 65(9):104557. PubMed ID: 35779834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.